These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22295404)

  • 1. Damage control surgery for liver rupture following selective internal radiation therapy for unresectable colorectal liver metastases.
    Latif E; Chua TC; Morris DL
    ANZ J Surg; 2011; 81(7-8):570-2. PubMed ID: 22295404
    [No Abstract]   [Full Text] [Related]  

  • 2. Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm.
    Hickey R; Lewandowski R; Salem R
    Ann Surg Oncol; 2015 Mar; 22(3):706-7. PubMed ID: 25358665
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases.
    Wasan HS
    Future Oncol; 2014 Nov; 10(15 Suppl):33-6. PubMed ID: 25478764
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer.
    Şendur MA; Bilgin B; Akıncı MB; Dede DS; Özdemir N; Ulas A; Zengin N; Yalçın B
    Future Oncol; 2017 Feb; 13(3):205-207. PubMed ID: 27646504
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
    Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
    World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective internal radiation therapy: a case of SIR-Sphere associated duodenal ulceration.
    Newland LR; Walsh A; Gilbert DR; Buckland ME
    Pathology; 2007 Oct; 39(5):526-8. PubMed ID: 17886108
    [No Abstract]   [Full Text] [Related]  

  • 7. Options for radiotherapy in the treatment of liver metastases.
    Gasent Blesa JM; Dawson LA
    Clin Transl Oncol; 2008 Oct; 10(10):638-45. PubMed ID: 18940744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing selective internal radiation therapy-based studies in the treatment of liver-dominant metastatic colorectal cancer.
    Heinemann V
    Future Oncol; 2014 Nov; 10(15 Suppl):37-9. PubMed ID: 25478765
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
    Wang DS; Louie JD; Sze DY
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective internal radiation therapy dosimetry.
    Kennedy A
    Future Oncol; 2014 Nov; 10(15 Suppl):77-81. PubMed ID: 25478774
    [No Abstract]   [Full Text] [Related]  

  • 11. Y90 selective internal radiation therapy.
    Lee EW; Thakor AS; Tafti BA; Liu DM
    Surg Oncol Clin N Am; 2015 Jan; 24(1):167-85. PubMed ID: 25444474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy in the treatment of solitary colorectal metastases to the liver.
    Donath D; Nori D; Turnbull A; Kaufman N; Fortner JG
    J Surg Oncol; 1990 May; 44(1):55-61. PubMed ID: 2342376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
    Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver.
    Martinez-Monge R; Nag S; Nieroda CA; Martin EW
    Cancer; 1999 Mar; 85(6):1218-25. PubMed ID: 10189125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.
    Saxena A; Meteling B; Kapoor J; Golani S; Morris DL; Bester L
    Ann Surg Oncol; 2015 Mar; 22(3):794-802. PubMed ID: 25323474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).
    Sangro B
    Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective internal radiation therapy for colorectal liver metastases: cart before the horse or otherwise?
    Morris DL
    ANZ J Surg; 2006 Aug; 76(8):675. PubMed ID: 16916380
    [No Abstract]   [Full Text] [Related]  

  • 19. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.